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Structural and functional analysis of hypoxia-inducible factor 1. Hy-
poxia-inducible factor I (HJF-1) is a basic helix-loop-helix protein that
activates transcription of hypoxia-inducible genes, including those encod-
ing: erythropoietin, vascular endothelial growth factor, heme oxygenase-1,
inducible nitric oxide synthase, and the glycolytic enzymes aldolase A,
enolase 1, lactate dehydrogenase A, phosphofructokinase L, and phospho-
glycerate kinasc 1. Hypoxia response elements from these genes consist of
a HIF-1 binding site (that contains the core sequence 5'-CGTG-3') as well
as additional DNA sequences that are required for function, which in
some elements include a second HIF-1 binding site. HIF-1 is a bet-
crodimer. The HtF-la subunit is unique to HIF-1, whereas RIF-lp
(ARNT) can dimerize with other bHLH-PAS proteins. Structural analysis
of HJF-la revealed that dimerization with HIF-113 (ARNT) requires the
HLH and PAS domains, DNA binding is mediated by the basic domain,
and that HIF-lo contains a carboxyl-terminal transactivation domain.
Co-transfection of 1-hF-la and HIF-lp (ARNT) expression vectors and a
reporter gene containing a wild-type hypoxia response element resulted in
increased transcription in non-hypoxic cells and a superinduction of
transcription in hypoxic cells, whereas HIF-1 expression vectors had no
effect on the transcription of reporter genes containing a mutation in the
HIF-1 binding site. HIF-lo and HIF-113 (ARNT) protein levels were
induced by hypoxia in all primary and transformed cell lines examined. In
HeLa cells, the levels of HIF-lo and HIF-1 protein and HIF-l DNA-
binding activity increased exponentially as cellular oxygen tension de-
creased, with maximum values at 0.5% oxygen and half-maximal values at
1.5 to 2% oxygen. HIF-lu and HIF-1J3 (ARNT) mRNAs were detected in
all human, mouse, and rat organs assayed and mRNA expression was
modestly induced in rodents subjected to hypoxia. HIF-lo protein levels
were induced in vivo when animals were subjected to anemia or hypoxia.
The HIF1A gene was mapped to human chromosome 14q21-q24 and
mouse chromosome 12.
This paper reviews recent investigations in our laboratory that
have attempted to determine the molecular mechanisms by which
the transcription factor hypoxia-inducible factor I (HIF-1) medi-
ates homeostatic responses to hypoxia in mammals. HIF-1 was
first identified [1] as a DNA-binding activity that was induced
when cultured cells were exposed to hypoxic conditions (1% 02)
[reviewed in 2—5]. We have continued to utilize cultured cells to
study the role of HIF-1, but we have now also begun the more
demanding process of analyzing HIF-1 expression in vivo.
Identification of target genes for activation by hF-I in
hypoxic cells
HIF-1 is a basic helix-loop-helix transcription factor that ap-
pears to be involved in many important homeostatic responses to
hypoxia. Genes whose transcription is activated by HIF-1 include
the following: (a) EPO, encoding erythropoietin, the primary
regulator of erythropoiesis and thus a major determinant of blood
02-carrying capacity [6]. (b) VEGF, encoding vascular endothehial
growth factor, the primary regulator of angiogenesis and thus a
major determinant of tissue perfusion [7—9]. (c) ALDA, ENOI,
LDHA, PFKL, and PGKJ, encoding the glycolytic enzymes aldo-
lase A, enolase 1, lactate dehydrogenase A, phosphofructokinase
L, and phosphoglycerate kinase 1, respectively, which provide a
metabolic pathway for ATP generation in the absence of 02
[10—12]. (d) HOl and iNOS, encoding heme oxygenase I and
inducible nitric oxide synthase, which are responsible for the
synthesis of the vasoactive molecules carbon monoxide and nitric
oxide, respectively [13, 14].
Analysis of hypoxia response elements
In the case of the EPO and VEGF genes, cis-acting DNA
sequences of 33 base pairs (bp) and 35 bp, respectively, have been
identified that are sufficient for hypoxia-induced transcription of
reporter genes and thus constitute hypoxia response elements
(HREs) [1, 8, 9]. These HREs have in common the presence of a
HIF-1 site and flanking sequences that are essential for function.
Mutation of the EPO sequence 5'-CACAG-3' located down-
stream of the HIF-1 site resulted in a complete loss of HRE
function. The sequence 5'-(C/A)ACAG-3' is also present both
immediately upstream and downstream of the HIF-1 site in the
VEGF gene. The factor which recognizes this sequence has not
been identified.
For other genes such as ENO1, HOl, LDHA, and PGKJ, the
minimal functional HRE sequence has not been precisely deter-
mined. However, these HREs are all characterized by the pres-
ence of two HIF-l sites within less than 30 bp. In the case of
ENO] and LDHA, mutation of one site completely eliminated
HRE function, whereas mutation of the other site severely
diminished, but did not eliminate the transcriptional response to
hypoxia, suggesting that the two sites did not function equiva-
lently. In the ALDA and EIVOI genes, sequences outside of the
functional HRE were identified that hound HIF-i in vitro but did
not contribute to the hypoxic response based upon mutagenesis
analysis in transfection assays, indicating that a HIF-1 site is
necessary but not sufficient for HRE function. Comparison of the
ten HIF-1 binding sites identified within the HREs described
above revealed an invariant core sequence S'-CGTG-3'.
Structural analysis of HIF-1
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Protein purification [15] and isolation of eDNA sequences [16]
revealed that HIF-1 is composed of two subunits. The HIF-lct
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subunit is an 826 amino acid protein whose sequence was not
previously reported, whereas the HIF-1/3 subunit is the protein
product of the ARNT gene which was previously shown to encode
774 and 789 amino acid isoforms of the aryl hydrocarbon receptor
(AHR) nuclear translocator protein [17]. ARNT can therefore
dimerize with HIF-la in cells subjected to hypoxia to form HIF-1
and can also dimerize with AHR in cells exposed to aryl hydro-
carbons such as dioxin to form the AHR complex. Additional
transcription factors that may utilize ARNT as a dimerization
partner include three Drosophila hHLH-PAS proteins: single-
minded (SIM) [181, similar (SIMA) [19], and trachealess (TRH)
[20, 21].
The HIF-lu and HIF-1f3 (ARNT) proteins share the following
structural motifs in common [6, 22]: (a) The bHLH, or basic
helix-loop-helix domain, is the hallmark of an extensive superfam-
ily of transcription factors. The HLH domains mediate protein
dimerization that is necessary for DNA binding mediated by the
basic domains. (b) Whereas the HLH domain is sufficient for
dimerization of most bHLH proteins, HIF-lcs and HIF-1f3
(ARNT) contain a second required dimerization domain, PAS,
which was originally identified by the presence of related se-
quences in the PER (which does not contain a bHLH domain),
ARNT, and SIM proteins [171. All PAS domains contain two
internal homology units of approximately 50 amino acids, the A
and B repeats, each of which contains an invariant HXXD motif
(H, histidine; X, any amino acid; D, aspartate) [161. For HIF-la
and HIF-113 (ARNT), the HLH and PAS domains together create
a functional interface for subunit protein-protein dimerization. (c)
The carboxyl half of the HIF-lu and HIF-1f3 (ARNT) proteins
contain one or more potent transactivation domains which are
presumed to interact directly or indirectly with components of the
transcription initiation complex and thus affect the rate of tran-
scription of genes to which they have bound.
Functional analysis of HIF-1
To demonstrate directly that HIF-1 functions as a transcrip-
tional activator, cultured cells were co-transfected with (a) re-
porter plasmids containing an HRE from the ENOJ, EPO, or
VEGF gene and (b) effector plasmids that allow constitutive
expression of HIF-la and HIF-1/3 (ARNT) from a cytomegalovi-
rus promoter [6, 9]. Forced expression of H1F-1 activated reporter
gene transcription in non-hypoxic cells and caused a superactiva-
tion in hypoxic cells. Reporter genes that contained an HRE with
a mutation that disrupted HIF-1 binding did not respond to
hypoxia or expression of recombinant HIF-1, demonstrating that
transcriptional activation required sequence-specific binding of
HIF-1. Whereas reporter gene transcription was activated by
co-transfected HIF-la expression vector in a dose-dependent
manner, there was no effect of added HIF-lp (ARNT) expression
vector, suggesting that HlF-1 (ARNT) is present in excess
relative to HIF-1 cs in both non-hypoxic and hypoxic cells.
To identify HIF-la sequences required for transactivation of
reporter genes in hypoxic cells, we co-transfected a reporter
plasmid, an effector plasmid encoding full-length HIF-I3(ARNT) and either full-length or deletion mutants of HIF-la.
Expression of full-length HIF-in (aa 1-826) resulted in 7- and
29-fold higher levels of reporter gene transcription at 20% and
1% 02, respectively, than in the absence of expression vectors [6].
Expression of the mutant HIF-lu (aa 1-390) resulted in only 4-
and 6-fold increases over control levels at 20% and 1% 02,
respectively. These results indicate that the carboxyl-terminal half
of HIF-la is required for transactivation in hypoxic cells, whereas
transactivation in non-hypoxic cells may be partially mediated by
other sequences such as the HIF-lp (ARNT) transactivation
domain. Analysis of nuclear extracts from transfected cells by gel
shift and immunoblot assays revealed that the mutant HIF-in (aa
1-390) protein was expressed at higher levels than full length
HIF-la, indicating that the deletion specifically affected transac-
tivation [6].
We also constructed an effector plasmid which constitutively
expressed a mutant form of HIF-la that lacked both the basic
domain and transactivation domain, such that it could dimerize
with HIF-ip (ARNT) but the resulting heterodimer could not
bind to DNA or activate transcription. Co-transfection of this
dominant-negative mutant form of HIF-lcr resulted in a dose-
dependent repression of reporter gene transcription in hypoxic
cells, thus demonstrating that the endogenous activation of re-
porter genes in hypoxic cells was also mediated by HIF-1 [6, 9].
HIF-1 expression as a function of cellular oxygen concentration
We performed a series of experiments in collaboration with H.
Marti and C. Bauer (Institute of Physiology, Zurich, Switzerland)
to determine the relationship between HIF-1 expression and
cellular oxygen concentration. HeLa cells were incubated over a
range of physiologic and pathophysiologic 02 concentrations,
either in the absence or presence of 1 mrvt KCN to block oxidative
phosphorylation and eliminate any intracellular or extracellular
02 gradients resulting from °2 consumption, and nuclear extracts
were prepared for gel shift and immunoblot assays. HIF-lu
protein, HIF-1f3 (ARNT) protein, and HIF-1 DNA-binding activ-
ity all increased exponentially as cellular 02 concentrations were
decreased from 20% to 0.5% 02 both in the presence and absence
of KCN [23]. For all three parameters, the curves showed a point
of inflection at 4 to 5% 02, the response was half-maximal at 1.5
to 2% °2' and maximal at 0.5% 02. The magnitude of the HIF-la
induction was much greater than that of HIF-lp as might be
expected given that HIF-1f3 is present in excess and that HIF-la
is the subunit specific to HIF-l. In vivo measurements have
revealed that °2 concentrations in most tissues under normal
physiologic conditions are in the range of 2 to 5%, indicating that
any decrease in tissue oxygenation would occur along the steep
portion of the HIF-l response curve [24]. If cells in vivo respond
in a manner similar to HeLa cells in culture, then the induction of
HIF-1 expression could provide a means to activate homeostatic
transcriptional responses that are proportional to the degree of
the inciting hypoxic stimulus.
Expression of HIF-1 in vivo
HIF-in and HIF-1J3 mRNAs were detected by blot hybridiza-
tion in all human tissues assayed, including brain, heart, kidney,
lung, liver, pancreas, placenta, and skeletal muscle [24]. In
addition, a BLAST search of the expressed sequence tag database
(dbEST) identified HIF-la expression in bone, fetal and adult
brain, pancreatic islets, placenta, retina, uterus, and white blood
cells. The ubiquitous expression of HIF-la and HIF-lp mRNA is
consistent with the proposed role of HIF-l in coordinating
homeostatic responses to hypoxia throughout the body. To deter-
mine whether HIF-1 mRNA expression was induced by hypoxia in
vivo, rats were exposed to 21% or 7% 02 for one hour prior to
RNA isolation. HIF-la and HIF-l/3 mRNAs were detected in
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brain, heart, kidney, liver, lung, and spleen [24]. Modest increases
in HIF- 1 mRNA levels were demonstrated in brain, kidney, and
lung tissue from hypoxic rats. In C57BL/6J mice, the basal levels
of HIF-lcs mRNA were lower than in rats, allowing a clearer
demonstration of the induction by hypoxia in brain, kidney, and
lung [24].
Genetics of hF-i
The ARNT gene was previously assigned to mouse chromosome
3 and human chromosome 1q21 [25]. HIFIA was assigned to
human chromosome 14q21-q24 by analysis of somatic cell hybrids
and by fluorescence in situ hybridization [26]. Hifla was localized
by interspecific hackcross analysis [26] within a region of mouse
chromosome 12 encompassing > 30 CM that demonstrates con-
servation of synteny with a region of human chromosome 14
extending from PAX9 at 14q12-q13 to IGHC at 14q32.33 [27].
Although the Ahr gene also maps to mouse chromosome 12, that
locus falls outside the region of conserved synteny and the human
AHR locus maps to chromosome 2 [reviewed in 271. Based upon
these data, there does not appear to be any clustering of genes
encoding bHLH-PAS proteins in the human or mouse genome.
Reprint requests to Gregg L. Semenza, M.D., Ph.D., Center for Medical
Genetics, Johns Hopkins Hospital, CMSC-1004, 600 North Wolfe Street,
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